$Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real‐world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group$

Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real‐world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hematology 2017-06, Vol.92 (6), p.E105-E107
Hauptverfasser:	Michallet, Anne‐Sophie, Campidelli, Arnaud, Lequeu, Helene, Dilhuydy, Marie‐Sarah, Tournilhac, Olivier, Fornecker, Luc‐Matthieu, Dupuis, Jehan, Cymbalista, Florence, De Guibert, Sophie, Delmer, Alain, Vilque, Jean‐Pierre, Ghez, David, Leblond, Veronique, Subtil, Fabien, Feugier, Pierre, Ysebaert, Loic
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Cardiovascular Diseases - chemically induced Chronic lymphocytic leukemia Dose-Response Relationship, Drug Female France - epidemiology Gastrointestinal Diseases - chemically induced Geriatrics Hematologic Diseases - chemically induced Hematology Human health and pathology Humans Infections - etiology Inhibitor drugs Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Life Sciences Lymphatic leukemia Male Molecular Targeted Therapy Protein Kinase Inhibitors - administration & dosage Protein Kinase Inhibitors - adverse effects Protein Kinase Inhibitors - therapeutic use Pyrazoles - administration & dosage Pyrazoles - adverse effects Pyrazoles - therapeutic use Pyrimidines - administration & dosage Pyrimidines - adverse effects Pyrimidines - therapeutic use Salvage Therapy Targeted cancer therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	0361-8609 1096-8652
DOI:	10.1002/ajh.24715